Novel strategies to prevent and treat experimental pneumococcal disease

Pharmacology, Toxicology and Pharmaceutical Science

• Pneumolysin 87%
• Pneumococcus Vaccine 50%
• MF1 Mouse 25%
• Polysaccharide 25%
• Conjugate Vaccine 12%
• Polysaccharide Vaccine 12%
• Carrier Protein 12%
• Virulence Factor 12%
• Pore-Forming Toxin 12%
• Pneumococcal Infection 12%
• Adhesin 12%
• Streptococcus 12%

Immunology and Microbiology

• Serotype 100%
• MF1 Mouse 18%
• Conjugate Vaccine 9%
• Streptococcus 9%
• Streptococcus Pneumoniae 9%
• Polysaccharide Vaccine 9%
• Nasopharynx 9%
• Cytotoxicity 9%
• Virulence Factor 9%
• Amino Terminal Sequence 9%